- Home
- NVCR vs SGHC Comparison
NVCR vs SGHC Comparison
Compare NVCR & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCR | SGHC |
|---|---|---|
| Founded | 2000 | 2020 |
| Country | Switzerland | Guernsey |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 5.8B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVCR | SGHC |
|---|---|---|
| Price | $13.26 | $11.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $28.42 | $16.00 |
| AVG Volume (30 Days) | 1.8M | ★ 2.0M |
| Earning Date | 10-30-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 1.34% |
| EPS Growth | N/A | ★ 4925.62 |
| EPS | N/A | ★ 0.45 |
| Revenue | $642,269,000.00 | ★ $2,342,912,011.00 |
| Revenue This Year | $9.75 | $28.87 |
| Revenue Next Year | $5.62 | $10.07 |
| P/E Ratio | ★ N/A | $26.45 |
| Revenue Growth | 11.17 | ★ 34.94 |
| 52 Week Low | $10.70 | $5.45 |
| 52 Week High | $31.17 | $14.38 |
Technical Indicators
Market Signals| Indicator | NVCR | SGHC |
|---|---|---|
| Relative Strength Index (RSI) | 56.27 | 54.47 |
| Support Level | $12.30 | $11.21 |
| Resistance Level | $13.97 | $12.16 |
| Average True Range (ATR) | 0.54 | 0.41 |
| MACD | 0.07 | 0.08 |
| Stochastic Oscillator | 63.71 | 77.10 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.